Publications by authors named "Ally Wardell"
Article Synopsis
- Fertility preservation (FP) is not commonly used by women diagnosed with cancer, partly due to concerns about delays in treatment and future reproductive success.
- A study analyzed data from women aged 15 to 39 with cancer in North Carolina, comparing outcomes between those who used FP and those who didn't, focusing on assisted reproductive technology (ART) use.
- Results showed that using FP delayed cancer treatment by up to 4.5 weeks but did not significantly impact prognosis, and women who initiated ART before treatment had better odds of live births, underscoring the need for more research on gestational carriers in cancer patients.
Purpose: Women face multiple barriers to fertility preservation after cancer diagnosis, but few studies have examined disparities in use of these services.
Methods: Women aged 15-39 years diagnosed with cancer during 2004-2015 were identified from the North Carolina Central Cancer Registry and linked to the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Women who cryopreserved oocytes or embryos for fertility preservation (n = 96) were compared to women who received gonadotoxic treatment but did not use fertility preservation (n = 7964).